1. Home
  2. FSTR vs LUNG Comparison

FSTR vs LUNG Comparison

Compare FSTR & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSTR
  • LUNG
  • Stock Information
  • Founded
  • FSTR 1902
  • LUNG 1995
  • Country
  • FSTR United States
  • LUNG United States
  • Employees
  • FSTR N/A
  • LUNG N/A
  • Industry
  • FSTR Metal Fabrications
  • LUNG Industrial Specialties
  • Sector
  • FSTR Industrials
  • LUNG Health Care
  • Exchange
  • FSTR Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • FSTR 220.4M
  • LUNG 299.3M
  • IPO Year
  • FSTR N/A
  • LUNG 2020
  • Fundamental
  • Price
  • FSTR $20.51
  • LUNG $7.77
  • Analyst Decision
  • FSTR Hold
  • LUNG Strong Buy
  • Analyst Count
  • FSTR 1
  • LUNG 7
  • Target Price
  • FSTR $25.00
  • LUNG $12.64
  • AVG Volume (30 Days)
  • FSTR 51.1K
  • LUNG 464.2K
  • Earning Date
  • FSTR 03-04-2025
  • LUNG 04-30-2025
  • Dividend Yield
  • FSTR N/A
  • LUNG N/A
  • EPS Growth
  • FSTR 2892.31
  • LUNG N/A
  • EPS
  • FSTR 3.89
  • LUNG N/A
  • Revenue
  • FSTR $530,765,000.00
  • LUNG $83,789,000.00
  • Revenue This Year
  • FSTR $10.37
  • LUNG $17.96
  • Revenue Next Year
  • FSTR $4.98
  • LUNG $18.35
  • P/E Ratio
  • FSTR $5.31
  • LUNG N/A
  • Revenue Growth
  • FSTR N/A
  • LUNG 22.01
  • 52 Week Low
  • FSTR $14.23
  • LUNG $5.46
  • 52 Week High
  • FSTR $30.77
  • LUNG $10.01
  • Technical
  • Relative Strength Index (RSI)
  • FSTR 31.03
  • LUNG 52.56
  • Support Level
  • FSTR $20.05
  • LUNG $7.65
  • Resistance Level
  • FSTR $20.86
  • LUNG $8.12
  • Average True Range (ATR)
  • FSTR 1.00
  • LUNG 0.49
  • MACD
  • FSTR 0.01
  • LUNG -0.06
  • Stochastic Oscillator
  • FSTR 15.89
  • LUNG 45.71

About FSTR L.B. Foster Company

L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: